Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT.
Naghavi-Behzad M, Vogsen M, Vester RM, Olsen MMB, Oltmann H, Braad PE, Asmussen JT, Gerke O, Vach W, Kidholm K, Kodahl AR, Weber W, Hildebrandt MG.
Naghavi-Behzad M, et al. Among authors: vogsen m.
Br J Cancer. 2022 May;126(9):1271-1279. doi: 10.1038/s41416-021-01654-w. Epub 2022 Jan 10.
Br J Cancer. 2022.
PMID: 35013575
Free PMC article.